NCT04073368 - Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

March 31, 2020

Study Completion Date

September 3, 2020

Conditions

NAFLD

Interventions

DIETARY_SUPPLEMENT

AXA1957

Amino acids, food study

DIETARY_SUPPLEMENT

AXA1125

Amino acids, food study

DIETARY_SUPPLEMENT

Placebo

Amino acids, food study

Trial Locations (18)

20874

Gastro One, Germantown

32789

Compass Research, LLC - Orlando, Orlando

32806

Bioclinica Research, Orlando

33427

Excel Medical Clinical Trials, LLC, Boca Raton

34202

Florida Digestive Health Specialists, Lakewood Rch

39056

Southern Therapy and Advanced Research LLC, Jackson

64030

Kansas City Research Institute, Kansas City

73301

Pinnacle Clinical Research, Austin

75234

Liver Center of Texas, Dallas

76104

Texas Digestive Disease Consultants (TDDC) - Downtown Fort Worth, Fort Worth

78201

Pinnacle Clinical Research, San Antonio

78504

Doctors Hospital at Renaissance, LLC, Edinburg

85224

The Institute for Liver Health LLC, Chandler

85641

The Institute for Liver Health LLC, Tucson

90010

National Research Institute - Wilshire, Los Angeles

90255

National Research Institute, Huntington Park

91402

National Research Institute - Panorama, Panorama City

91762

Catalina Research Institute, LLC, Montclair